Description

• FELOCELL^® 4 contains attenuated strains of feline herpesvirus-1 (FHV-1), feline calicivirus (FCV), and feline parvovirus (FPV) (Johnson Snow Leopard strain) propagated on established cell lines.



• Felocell 4 contains Chlamycia psittaci propagated on established cell lines.



• Packaged in freeze-dried form with inert gas in place of vacuum.

• Vaccination of healthy cats as an aid in preventing feline viral rhinotracheitis (FVR) caused by FHV-1, respiratory disease caused by FCV, feline panleukopenia (FPL) caused by FPV, and feline chlamydiosis caused by Chlamydia psittaci.

• FELOCELL 4 contains the potent, proven Johnson Snow Leopard strain of FPV for reliable protection against FPL.



• FELOCELL 4 provides protection against two viral agents accounting for 90 percent of feline upper respiratory disease.



• FELOCELL 4 provides all the feline viral respiratory protection of FELOCELL 3 plus protection against ocular and respiratory disease caused by C. psittaci.



• Customer-friendly packaging using recycled materials includes peel-off labels to make record-keeping faster and more accurate, a color-coded organizing system, and an easy-open safety band.

• General directions: Vaccination of healthy cats is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well, and administer 1 mL intramuscularly or subcutaneously.



• Primary vaccination: Healthy cats 12 weeks of age or older should receive 2 doses administered 3 to 4 weeks apart. Cats vaccinated at less than 12 weeks of age should be revaccinated at 12 weeks of age.



• Revaccination: Annual revaccination with a single dose is recommended.

• Store at 2°–7° C. Prolonged exposure to higher temperature and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer FELOCELL 4. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine. Burn containers and all unused contents.



• As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.



• This product has been shown to be efficacious in healthy animals. A protective immune response may not develop if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or if the vaccine is not administered according to label directions.



• The use of FELOCELL 4 has been associated with fever, anorexia, and lethargy in 1% of vaccinated cats, often occurring with multiple concurrent vaccinations. Onset typically occurs 7 to 21 days after vaccination, with symptoms persisting for 3 to 30 days, with an average of 12 days. Treatment typically involves supportive care, steroids, and antibiotics.



• Vaccination of pregnant queens should be avoided. For use in cats only.



• For veterinary use only.